Free Consultation (800) 424-6690 Free Consultation (800) 424-6690 | [email protected]

Newsroom Search

featured news

April 9, 2014 Healthcare Fraud

Arkansas Supreme Court Takes Different View of Risperdal Fraud Case

Late last year, the federal Department of Justice settled a long-running dispute with drug maker Johnson & Johnson over allegations of the off-label marketing of the anti-psychotic drug Risperdal. As is often the case, Johnson & Johnson also faced several state False Claims Act and Deceptive Trade Practices Act allegations, […]
February 28, 2014 Healthcare Fraud

Pharmaceutical Sales Whistleblower Sheds Light on Off-Label Marketing Scheme

It is unlawful for a pharmaceutical company to market a drug for purposes beyond those that have been approved by the Food and Drug Administration. When a company decides to sell a new drug to American consumers, the FDA ensures the drug is rigorously tested to reveal any deadly or […]
schedule a free consultation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

in Settlements & Verdicts
Years of High-Profile Cases
Attorneys Protecting Your Rights
Named “Trial Lawyer of the Year”
States in Which The Firm Has Successfully Litigated Cases

On the Cutting Edge of the Profession

Legal Intelligencer